af-001
Thyroid Cancer (Radioiodine-Naïve)
Phase 1Active
Key Facts
About Alpha Fusion
A Japanese biotech developing targeted alpha therapies using Astatine-211 for precise cancer treatment with minimal side effects.
View full company profileThyroid Cancer (Radioiodine-Naïve)
A Japanese biotech developing targeted alpha therapies using Astatine-211 for precise cancer treatment with minimal side effects.
View full company profile